<VariationArchive VariationID="3248396" VariationName="NC_000019.9:g.(?_12760707)_(12761056_?)del" VariationType="Deletion" Accession="VCV003248396" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3407208" VariationID="3248396">
      <GeneList>
        <Gene Symbol="MAN2B1" FullName="mannosidase alpha class 2B member 1" GeneID="4125" HGNC_ID="HGNC:6826" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12646512" stop="12666742" display_start="12646512" display_stop="12666742" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12757321" stop="12777590" display_start="12757321" display_stop="12777590" Strand="-" />
          </Location>
          <OMIM>609458</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000019.9:g.(?_12760707)_(12761056_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" innerStart="12760707" innerStop="12761056" display_start="12760707" display_stop="12761056" variantLength="350" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.(?_12760707)_(12761056_?)del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.(?_12760707)_(12761056_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000019.9:g.(?_12760707)_(12761056_?)del AND Deficiency of alpha-mannosidase" Accession="RCV004581030" Version="1">
        <ClassifiedConditionList TraitSetID="428">
          <ClassifiedCondition DB="MedGen" ID="C0024748">Deficiency of alpha-mannosidase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22161967</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9915946</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="428" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2728" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lysosomal alpha-D-mannosidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha mannosidase B deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mannosidosis, alpha B lysosomal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha-Mannosidosis</ElementValue>
                <XRef ID="NBK1396" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of alpha-mannosidase</ElementValue>
                <XRef ID="Alpha-Mannosidosis+Type+1/332" DB="Genetic Alliance" />
                <XRef ID="124466001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MANSA</ElementValue>
                <XRef Type="MIM" ID="248500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6968" />
                <XRef ID="6968" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Alpha-mannosidosis encompasses a continuum of clinical findings from mild to severe. Three major clinical subtypes have been suggested: A mild form recognized after age ten years with absence of skeletal abnormalities, myopathy, and slow progression (type 1). A moderate form recognized before age ten years with presence of skeletal abnormalities, myopathy, and slow progression (type 2). A severe form manifested as prenatal loss or early death from progressive central nervous system involvement or infection (type 3). Individuals with a milder phenotype have mild-to-moderate intellectual disability, impaired hearing, characteristic coarse features, clinical or radiographic skeletal abnormalities, immunodeficiency, and primary central nervous system disease â€“ mainly cerebellar involvement causing ataxia. Periods of psychiatric symptoms are common. Associated medical problems can include corneal opacities, hepatosplenomegaly, aseptic destructive arthritis, and metabolic myopathy. Alpha-mannosidosis is insidiously progressive; some individuals may live into the sixth decade.</Attribute>
                <XRef ID="NBK1396" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301570</ID>
                <ID Source="BookShelf">NBK1396</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21368911</ID>
              </Citation>
              <XRef ID="61" DB="Orphanet" />
              <XRef ID="C0024748" DB="MedGen" />
              <XRef ID="MONDO:0009561" DB="MONDO" />
              <XRef Type="MIM" ID="248500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9838953" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000019.9:g.(?_12760707)_(12761056_?)del|MedGen:C0024748" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005063574" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9915946</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22161967</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 17-18 of the MAN2B1 gene. This deletion is out-of-frame, and is expected to create a premature termination codon and result in an absent or disrupted protein product. Loss-of-function variants in MAN2B1 are known to be pathogenic (PMID: 9915946, 22161967). This variant has not been reported in the literature in individuals affected with MAN2B1-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.(?_12760707)_(12761056_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024748" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9838953" TraitType="Disease" MappingType="XRef" MappingValue="C0024748" MappingRef="MedGen">
        <MedGen CUI="C0024748" Name="Deficiency of alpha-mannosidase" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

